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the cellular proliferation in either HBeAg(+) or HBeAg(−)
patients, and markedly enhanced the IFN- production in
HBeAg(+) patients.
Conclusion: The persistency of HBeAg could induce higher
expression of PD-1 and CTLA-4 on the HBV-speciﬁc T cells,
which may associate with the low ability of HBV-speciﬁc
T-cell responses, high serum HBV DNA levels and high per-
centage of liver cirrhosis in HBeAg(+) CHB patients.
doi:10.1016/j.ijid.2008.05.1246
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Background/aims: In order to deﬁne the clinical, sero-
logical and virological aspects, including viral genotypes
and mutations, of acute hepatitis B virus infection (AHB)
a prospective study has been carried out in Italy.
Methods: AHB cases referred to 17 hospitals were
recruited over 1 year and followed-up for 6 months. Bio-
chemical and virological assessments were done 7, 15, 30
days after disease onset, and then at 3-month interval.
Results: Overall, 111 patients were enrolled. All patients
were IgM anti-HBc+, 108 were HBsAg+ and 70 of the 72
patients tested for HBV-DNA were positive. A preliminary
analysis was performed on 99 of 111 cases: 21 were followed-
up for > 6 months, 25 for 3—6 months, 53 for 6 months
(95.2%). HBV-DNA negativization occurred after HBsAg neg-
ativization, but after a 6-month follow-up results on HBsAg
and HBV-DNA were concordant. The frequency of HBV geno-
type in 49 patients was: genotype D, 59.2%; genotype A,
36.7%; genotype F, 4.1%. Core/pre-core mutants, detected
in 21of 34 patients examined (61.8%), were more frequent
in genotype D infection.
Conclusion: The frequent detection of anti-HBe+ and
anti-HBe/HBeAg+ patients in the early disease phase, as
well as the long-lasting persistence of IgM anti-HBc, rep-
resents novel ﬁndings in the ﬁeld of AHB. The correlation
between HBsAg and HBV-DNA makes HBsAg a useful marker
of virus clearance. Genotype distribution and core/per-core
mutations frequency conﬁrm previous ﬁndings.
doi:10.1016/j.ijid.2008.05.1251
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Introduction: Improvements in hygiene and sanitation
standards have determined a dramatic decrease in HAV cir-
culation in Italy. HAV exposure is now less common during
childhood, while a growing number of susceptible young
adults has developed. Using data of the Italian surveillance
system of acute hepatitis (SEIEVA), we evaluated the inci-
dence of and risk factors for acute hepatitis A (AHA).
Methods: We performed a case-control study within a
population-based surveillance for acute viral hepatitis. AHA
incidence was estimated since 1991; the association with
considered risk factors was analysed during 2001—2006,
using cases of acute hepatitis B (AHB) as controls
Results: The incidence declined from 4/100,000 in 1991
to 1.4/100,000 in 2006, peaking during 1996—97 due to an
outbreak in South Italy. The incidence was higher in per-
sons aged 15—24 years. The lethality was 2.9/10,000. During
the period 1991—2006 82 cases were notiﬁed among vacci-
nated subjects: 95% of these HAV cases received vaccine
within 1 months from the onset. Contact with individuals
with AHA (ORadj = 3.8; 95%CI 2.7—5.5) travelling to endemic
areas (ORadj = 3.1; 95%CI = 2.6—3—8) ingestion of raw shell-
ﬁsh (ORadj = 1.8; 95%CI = 1.6—2.1) and cohabitation with
a day-care child (ORadj = 1.3; 95%CI = 1.01—1.7) were the
most important risk factors. In 2003 intravenous drug use
caused an outbreak, with high lethality in a central Italian
town. In this analysis, male homosexuality was not asso-
ciated with AHA, while a weak association was found by
using acute hepatitis C cases as controls (ORadj = 1.44 CI,
95%CI = 1.06—1.95).
Discussion: HAV infections is nowadays more frequent
in adults, in which the disease is more severe. Travel
in endemic areas and contact with AHA cases are the
most important risk factors, while shellﬁsh consumption has
become a less frequent way for acquiring AHA. Vaccination
of individuals at increased risk of infection combined with
surveillance of retail outlet of shellﬁsh are efﬁcient control
measures.
doi:10.1016/j.ijid.2008.05.1252
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Background and aims: Invasive procedures (IP) are fre-
quently reported risk factor for both acute hepatitis B (AHB)
and C (AHC). We estimated the association between par-
enteral viral hepatitis and speciﬁc types of IP.
Methods: Data from the surveillance for acute viral hep-
atitis during 2000—2006 were used. The association of AHB
and AHC with different IP was estimated comparing 3,506
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AHB and 769 AHC cases with 4,874 hepatitis A cases, used
as controls.
Results: For AHC, the strongest associations were with
urological [Adjusted Odd Ratio (ORadj,17.5; Cinﬁdence
Interval (CI), 1.6—187.1), neurological (ORad, 16.2, CI,
2.7—97.7), and minor surgery (ORad,10.9; CI,3.6—32.6). A
lower but signiﬁcant risk (from 3,7 to 4,7 times higher
respect to no intervention) was found for oral surgery,
Gynaecological, cardiovascular, abdominal interventions
and for biopsy or endoscopy. Only minor (ORad,3.0; CI,
1.3—7.1), oral (ORad, 2.6; CI,1.5—4.6) and dermatological
surgery (ORad, 2.9; CI, 1.1—7.5) were associated with AHB
instead, instead.
Conclusion: Although AHB and AHC incidences are declin-
ing, IP still represent important risk factors. The differences
in risk estimation between AHB and AHC is likely due to
the higher HCV prevalence in the general population; admit-
ting a person-to-person transmission by breaks in universal
precautions, the larger pool of subjects infected with HCV
than HBV makes more likely the exposure to HCV. The
increasing proportion of HBV-immunized young adults and
vaccination of high risk groups, further explain these differ-
ences. The high risk found for minor surgery, might suggest
that healthcare providers underrate the risk connected with
this procedure. Since a lot of people is exposed to IP
and an effective HCV vaccine is not yet available, these
ﬁndings underscore the importance of implementing non-
immunologic preventive measures to control iatrogenic HBV
and HCV transmission.
doi:10.1016/j.ijid.2008.05.1253
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Background: The ability to predict a favorable outcome of
treatment is a major issue in the management of hepatitis C.
Based on results of the viral kinetics studies, which indicated
a two-phase reduction in HCV RNA levels after IFN treatment
initiation, with the ﬁrst one appearing to be predictive of
response, we monitored the utility of the rapid virological
response (RVR), deﬁned as undetectable HCV RNA at week
4.
Methods: Samples from 38 patients (all females, mean
age 48,4± 5 ys) with chronic hepatitis C, but without signs
of cirrhosis, were tested for HCV viral load by quantitative
Rt- PCR (COBAS Amplicor HCV Monitor, Roche Diagnos-
tics) before initiation of treatment with PEG-IFN-alpha-2a
(180mcg/week) in combination with ribavirin (800mg/day)
for 48 weeks, at week 4 and at 6 month after the completion
of therapy. Genotyping was performed using a commercial
Line Probe Assay (Innogenetics).
Results: All patients had high baseline viral load
(>700 0000 IU/ml) and were infected with genotype 1b.
Despite these negative predictors for treatment success,
21 patients (75%) achieved a sustained virologic response
(SVR)- undetectable viral load at 6 month after discontinu-
ation of treatment. At week 4 after treatment initiation, 18
patients (64%) had undetectable viral load HCV. Out of these
rapid responders 17 (95%) achieved a SVR and only relapsed
at 6 month.By contrast, only 4 patients (36.4%) with HCV
RNA≥ 600 IU/ml at week-4 achieved an SVR.
Conclusion: The RVR may be a useful indicator for
the duration and long term outcome of treatment among
patients with chronic HCV infection, even in countries like
Romania, where genotype 1b is the most common. Lack of
RVR can justify discontinuation of therapy, with important
reduction in associated costs and adverse effects, while a
good response at week 4 indicates a low risk of relapses,
even in the presence of a less-sensitive genotype.
doi:10.1016/j.ijid.2008.05.1254
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Introduction: Hepatitis C virus (HCV) infection has
reached epidemic proportions. Worldwide, more than one
million new cases of infection are reported annually, and
HCV is believed to be more prevalent than hepatitis B virus
infection and 80% of the affected will be chronically infected
and are at risk of serious chronic sequel including cirrho-
sis and hepatocellolar carcinoma. Genotyping of HCV is
becoming increasingly important for clinical management of
chronic infection and as an epidemiological marker. At least
six major genotypes of HCV, each comprising multiple sub-
types, have been identiﬁed. Substantial regional differences
appear to exist in the distribution of genotypes. Although
HCV genotypes 1, 2, and 3 appear to have a worldwide distri-
bution, their relative prevalence varies from one geographic
area to another. subtypes 1a and 1b in the United States and
Europe, In Japan, subtype 1b, in northern Italy Subtype 2c,
Genotype 4 in North Africa and the Middle East, genotypes
5 and 6 in South Africa and Hong Kong are the most common
genotypes. Genotypes 7, 8, and 9 have been identiﬁed only
in Vietnamese patients, and genotypes 10 and 11 were iden-
tiﬁed in patients from Indonesia. We conducted this study to
detect the most common genotype in major thalassaemics
patients.
Methods and materials: We enrolled 52 patients of
HCV positive in a cross-sectional study. we used ELISA,
Restrictive-Fragment length polymorphism analysis and PCR
methods.
Result: 51.9% were men and 48.1% women. The mean
age (±SD) was 22± 4.48. Genotype 1a was the most com-
mon type (53%) after that 3a (42%) and 1b (5%).average of
viral load in patients with 1a genotype was 363501.1 and
in patients with 3a was 346621.3 that shows no signiﬁcant
difference.
